Q2 How can APEC economies and businesses seize the AI opportunity, and what role can China's "AI Plus" initiative play in improving productivity and business performance?
PRASANNAN: China's "AI Plus" initiative reflects this approach by encouraging the integration of AI into industrial production, operations and services. For businesses across APEC, the opportunity is to move beyond experimentation and apply AI to practical challenges, from predictive maintenance and operational efficiency to more informed decision-making.
Digitalization sits alongside decarbonization as one of Everllence's core strategic pillars. AI's value also extends to the energy supply side: the rapid expansion of AI and cloud infrastructure is emerging as a major growth driver for our power business, for the demand of power generation for data centers, and it becomes a strategic focus for Everllence. Our engines for power plants can already operate on carbon-neutral fuels such as e-methane and biofuels. Selected engines are hydrogen-ready and can accommodate hydrogen blends of up to 25 percent, enabling operators to gradually decarbonize their energy infrastructure while maintaining energy security.
XIA: The real value of AI lies in its integration with industry. At Evonik, AI is already supporting research, production, marketing and knowledge management, helping accelerate innovation, optimize processes and improve sustainable management. China's "AI Plus" initiative can further unlock this potential by promoting the application of AI across the country's strong manufacturing base.
AI is also creating new markets. The rapid growth of AI infrastructure is driving demand for advanced materials. Evonik's solutions can be applied from advanced PCBs and substrates, chip packaging, and extreme thermal management to power systems and energy storage. As AI infrastructure continues to scale, demand for high-performance specialty materials is expected to grow across the value chain, creating new opportunities for both established solutions and innovations that are still advancing through testing and development stages.
ZHENG: AI is supporting drug discovery through applications such as target identification and molecular design. In clinical development, it can assist with feasibility assessment, site selection, document preparation and data-quality review. By reducing repetitive tasks and avoidable rework, AI can help teams make better-informed development decisions sooner and focus on more value-creating work.
China's "AI Plus" initiative can foster collaboration among technology developers, researchers and clinical development teams. Across APEC, sharing experience and building skills can help turn these applications into practical productivity gains. Validation, data protection and human oversight are essential to making that progress responsibly.
At Parexel, we combine AI with scientific, regulatory and operational expertise across our global network and Asia-Pacific teams. Launched in May 2026, ParexelAI supports activities from early development through post-market surveillance. In some cases, we achieved a 50 percent reduction in site-selection process timelines and a 30 percent reduction in clinical study report preparation time. Our focus is on translating these gains into faster, more coordinated development, while prioritizing human oversight and safeguarding patient safety and data integrity.
SHIH: China's "AI Plus" initiative promotes deeper integration of AI into the real economy. Combined with China's diverse industrial applications, this creates more opportunities for companies to scale AI deployment, improve productivity and deliver business results. Rockwell Automation's 11th Annual State of Smart Manufacturing Report found that 83 percent of respondents in China are using AI and machine learning to enhance operations and plan to expand their use over the next 12 months, compared with 72 percent globally.
As AI is deployed across an increasingly wider range of applications, companies need to focus on how it addresses specific business challenges. Rockwell Automation advances AIoT convergence by integrating AI with information technology and operational technology, connecting data, processes and intelligent decision-making. In the consumer packaged goods sector, for example, reaching customers and responding to market demand also contribute to business performance alongside production efficiency.
For APEC economies and businesses, the opportunity lies in turning AI adoption into measurable improvements in productivity, competitiveness and long-term business performance. Cross-industry and cross-regional cooperation can help companies share experiences and adapt proven practices to local conditions. This can enable more businesses to benefit from AI and translate its adoption into sustained improvements in productivity.
